articleOphthalmologyMay 11, 2012Closed access

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

UCUsha ChakravarthySHSimon HardingCRChris RogersSMSusan M. DownesALAndrew Lotery

University of Liverpool · University of Bristol · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

775
total citations
FWCI
98.20
Percentile
100%
References
28
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Medicine
  • Macular degeneration
  • Ranibizumab
  • Bevacizumab
  • Ophthalmology
  • Choroidal neovascularization
  • Optometry
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.